These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 28239636)

  • 41. APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.
    Lim YY; Villemagne VL; Laws SM; Pietrzak RH; Snyder PJ; Ames D; Ellis KA; Harrington K; Rembach A; Martins RN; Rowe CC; Masters CL; Maruff P
    Mol Psychiatry; 2015 Nov; 20(11):1322-8. PubMed ID: 25288138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.
    Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ
    J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals.
    Sperling RA; Donohue MC; Raman R; Sun CK; Yaari R; Holdridge K; Siemers E; Johnson KA; Aisen PS;
    JAMA Neurol; 2020 Jun; 77(6):735-745. PubMed ID: 32250387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spatial Patterns of Longitudinal Gray Matter Change as Predictors of Concurrent Cognitive Decline in Amyloid Positive Healthy Subjects.
    Araque Caballero MÁ; Klöppel S; Dichgans M; Ewers M;
    J Alzheimers Dis; 2017; 55(1):343-358. PubMed ID: 27662291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative Susceptibility Mapping of Brain Iron and β-Amyloid in MRI and PET Relating to Cognitive Performance in Cognitively Normal Older Adults.
    Chen L; Soldan A; Oishi K; Faria A; Zhu Y; Albert M; van Zijl PCM; Li X
    Radiology; 2021 Feb; 298(2):353-362. PubMed ID: 33231528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amyloid-PET imaging offers small improvements in predictions of future cognitive trajectories.
    Ackley SF; Hayes-Larson E; Brenowitz WD; Swinnerton K; Mungas D; Fletcher E; Singh B; Whitmer RA; DeCarli C; Maria Glymour M
    Neuroimage Clin; 2021; 31():102713. PubMed ID: 34153689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sex-related differences in the relationship between β-amyloid and cognitive trajectories in older adults.
    Lindbergh CA; Casaletto KB; Staffaroni AM; La Joie R; Iaccarino L; Edwards L; Tsoy E; Elahi F; Walters SM; Cotter D; You M; Apple AC; Asken B; Neuhaus J; Rexach JE; Wojta KJ; Rabinovici G; Kramer JH;
    Neuropsychology; 2020 Nov; 34(8):835-850. PubMed ID: 33030915
    [No Abstract]   [Full Text] [Related]  

  • 48. Proper names from story recall are associated with beta-amyloid in cognitively unimpaired adults at risk for Alzheimer's disease.
    Mueller KD; Koscik RL; Du L; Bruno D; Jonaitis EM; Koscik AZ; Christian BT; Betthauser TJ; Chin NA; Hermann BP; Johnson SC
    Cortex; 2020 Oct; 131():137-150. PubMed ID: 32861209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amyloid-β₄₂ is associated with cognitive impairment in healthy elderly and subjective cognitive impairment.
    Rolstad S; Berg AI; Bjerke M; Blennow K; Johansson B; Zetterberg H; Wallin A
    J Alzheimers Dis; 2011; 26(1):135-42. PubMed ID: 21593572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of Mild Behavioral Impairment on Longitudinal Changes in Cognition.
    Rouse HJ; Ismail Z; Andel R; Molinari VA; Schinka JA; Small BJ
    J Gerontol A Biol Sci Med Sci; 2024 Jan; 79(1):. PubMed ID: 37052173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. β-Amyloid Deposition Is Associated with Decreased Right Prefrontal Activation during Task Switching among Cognitively Normal Elderly.
    Oh H; Steffener J; Razlighi QR; Habeck C; Stern Y
    J Neurosci; 2016 Feb; 36(6):1962-70. PubMed ID: 26865619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI.
    Lim YY; Pietrzak RH; Bourgeat P; Ames D; Ellis KA; Rembach A; Harrington K; Salvado O; Martins RN; Snyder PJ; Masters CL; Rowe CC; Villemagne VL; Maruff P
    Arch Clin Neuropsychol; 2015 Feb; 30(1):49-58. PubMed ID: 25467942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults.
    Lim YY; Ellis KA; Pietrzak RH; Ames D; Darby D; Harrington K; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Villemagne VL; Maruff P;
    Neurology; 2012 Oct; 79(16):1645-52. PubMed ID: 23071163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease.
    Porter T; Burnham SC; Savage G; Lim YY; Maruff P; Milicic L; Peretti M; Ames D; Masters CL; Martins RN; Rainey-Smith S; Rowe CC; Salvado O; Taddei K; Groth D; Verdile G; Villemagne VL; Laws SM
    Front Aging Neurosci; 2018; 10():423. PubMed ID: 30620773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergism between fornix microstructure and beta amyloid accelerates memory decline in clinically normal older adults.
    Rabin JS; Perea RD; Buckley RF; Johnson KA; Sperling RA; Hedden T
    Neurobiol Aging; 2019 Sep; 81():38-46. PubMed ID: 31207468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults.
    Pettigrew C; Soldan A; Moghekar A; Wang MC; Gross AL; O'Brien R; Albert M
    Neuropsychologia; 2015 Nov; 78():63-72. PubMed ID: 26394023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of
    Kang DW; Wang SM; Um YH; Kim NY; Lee CU; Lim HK
    Front Aging Neurosci; 2022; 14():871323. PubMed ID: 35677201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subjective Cognitive Decline Is Associated With Lower Baseline Cognition and Increased Rate of Cognitive Decline.
    Morrison C; Oliver MD
    J Gerontol B Psychol Sci Soc Sci; 2023 Apr; 78(4):573-584. PubMed ID: 36373799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detecting earlier stages of amyloid deposition using PET in cognitively normal elderly adults.
    Guo T; Landau SM; Jagust WJ;
    Neurology; 2020 Apr; 94(14):e1512-e1524. PubMed ID: 32188766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life.
    Gates NJ; Rutjes AW; Di Nisio M; Karim S; Chong LY; March E; Martínez G; Vernooij RW
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD012277. PubMed ID: 32104914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.